Scorecard › Nuclear (firm by firm) › CCJ

CCJ analyst scorecard

16 rating actions on CCJ in the last 12 months. Of 14 price targets that resolved, 4 were reached while they stood, 10 were replaced by the same firm first, and 0 fell short at their deadline. Ratings: 69% Buy-type, 31% Hold-type, 0% Sell-type. Consensus target $126, 51% above the last close.

Checked through 2026-10-29 · last close $83.10 (2026-10-29). Rebuilt every morning.

Targets reached while they stood
28.6% 4 of 14
Replaced before the deadline
71.4%
Short at the deadline
0.0%
Ratings vs XLE
3 of 4
Buy / Hold / Sell, 12 mo
69 / 31 / 0%
Consensus target
$126 +51.3%

What the Holds say: 5 Hold-type ratings on CCJ in the last 12 months carried a median target +18% from the price on the day; 0% sat below it.

Firm by firm

FirmLatest ratingDateLatest targetTargets reachedReplaced earlyResolvedRatings vs sector
RBC Capital Outperform2026-06-29 $175 0661 of 1
Barclays Equal-Weight2026-10-19 $95 011—
Bank of America Buy2026-07-09 $140 ——0—
Truist Securities Buy2026-10-22 $125 022—
William Blair Outperform2026-04-20 — ——0—
GLJ Research Buy2026-02-18 $171 1121 of 1
UBS Neutral2025-11-10 $140 ——0—
Goldman Sachs Buy2025-10-29 $109 2021 of 1

Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor CCJ carry a letter here. Why →

Every call, last 12 months

DateFirmRatingActionPrice at callTargetTarget statusMove in the 30 days before
2026-10-22 Truist Securities Buy maintained $78.93 $125 running to 2027-10-22 -16.6%
2026-10-19 Barclays Equal-Weight maintained $80.70 $95 running to 2027-10-19 -11.9%
2026-08-12 Truist Securities Buy maintained $99.03 $130 replaced 2026-10-22, new $125 +9.8%
2026-08-04 Barclays Equal-Weight maintained $93.09 $97 within 5% of price when set -3.6%
2026-07-16 Barclays Equal-Weight maintained $87.36 $104 replaced 2026-08-04, new $97 -19.0%
2026-07-14 Truist Securities Buy initiated $91.57 $129 replaced 2026-08-12, new $130 -9.3%
2026-07-09 Bank of America Buy maintained $95.74 $140 running to 2027-07-09 -6.4%
2026-06-29 RBC Capital Outperform maintained $103.47 $175 running to 2027-06-29 -8.2%
2026-05-22 Barclays Equal-Weight initiated $104.75 $108 within 5% of price when set -17.2%
2026-04-20 William Blair Outperform initiated $123.62 — no target +21.7%
2026-02-18 GLJ Research Buy reiterated $116.50 $171 running to 2027-02-18 +0.1%
2026-02-17 RBC Capital Outperform maintained $112.94 $160 replaced 2026-06-29, new $175 -3.0%
2025-11-13 RBC Capital Outperform maintained $85.98 $150 replaced 2026-02-17, new $160 —
2025-11-10 UBS Neutral initiated $94.24 $140 running to 2026-11-10 —
2025-10-31 RBC Capital Outperform maintained $102.21 $160 replaced 2025-11-13, new $150 —
2025-10-29 Goldman Sachs Buy maintained $106.67 $109 within 5% of price when set —

Also in Nuclear

OKLOSMRLEUBWXTNuclear vs URA →

Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.

How calls are checked

Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →

Get the daily brief

Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.